Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
"The '349 Patent validates JIVAN's position as a leader in the growing market for DNA microarrays to detect alternative splicing," said Subha Srinivasan, PhD, CEO of JIVAN. "Powerful data analysis is critical to the adoption of splicing arrays, the next generation of expression arrays."
The '349 Patent fits in JIVAN's broader strategy of providing a complete solution for splice isoform expression, ranging from array design to microarray services to data analysis to PCR validation.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!